3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Muscle Rigidity in 2 studies
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist
Muscle Rigidity: Continuous involuntary sustained muscle contraction which is often a manifestation of BASAL GANGLIA DISEASES. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish rigidity from MUSCLE SPASTICITY. (From Adams et al., Principles of Neurology, 6th ed, p73)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klockgether, T | 1 |
| Turski, L | 1 |
| Shinozaki, H | 1 |
| Ishida, M | 1 |
| Goto, Y | 1 |
2 other studies available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Muscle Rigidity
| Article | Year |
|---|---|
NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats.
Topics: Animals; Dizocilpine Maleate; Drug Synergism; Electromyography; Levodopa; Male; Methyltyrosines; Mot | 1990 |
Depression of decerebrate rigidity in the rat by antagonists of excitatory amino acids.
Topics: Amino Acids; Animals; Anticonvulsants; Azepines; Blood Pressure; Decerebrate State; Dibenzocyclohept | 1989 |